ConductScience.org, home

Paper29656372

Serum calprotectin may reflect inflammatory activity in patients with active rheumatoid arthritis despite normal to low C-reactive protein.

Hurnakova J and 8 others. Clin Rheumatol, 2018. Cited by 23 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Serum calprotectin may reflect inflammatory activity in patients with active rheumatoid arthritis despite normal to low C-reactive protein. Papers, record 29656372. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29656372

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Serum calprotectin may reflect inflammatory activity in patients with active rheumatoid arthritis despite normal to low C-reactive protein.
PubMed
Journal
Clin Rheumatol
PubMed
Year
2018
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
23
iCite
Relative citation ratio, by iCite
1.14
iCite
Revised in PubMed
2019-01-10
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hurnakova JJanahttps://orcid.org/0000-0002-1139-539X
2Hulejova HHana
3Zavada JJakub
4Komarc MMartin
5Cerezo LALucie Andres
6Mann HHerman
7Vencovsky JJiri
8Pavelka KKarel
9Senolt LLadislav

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Arthritis, RheumatoidMajor topic
C-Reactive ProteinMajor topic
Leukocyte L1 Antigen ComplexMajor topic
Biomarkers
Blood Sedimentation
Female
Finland
Humans
Male
Middle Aged
Reference Values
Severity of Illness Index

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
023728Project of the Ministry of Health of the Czech Republic for conceptual research development by organizationPubMed
260373Specific Academy Research Projects (SVV)PubMed

Source PubMed

Download CSV of grants

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT04201886Serum Calprotectin Level in Patients With Rheumatoid Arthritis and OsteoarthritisResults

Source ClinicalTrials.gov

Download CSV of trials

References30

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127832086Serum Calprotectin Discriminates Subclinical Disease Activity from Ultrasound-Defined Remission in Patients with Rheumatoid Arthritis in Clinical Remission.PLoS One2016https://conductscience.org/library/papers/27832086PubMed
227391315Calprotectin and TNF trough serum levels identify power Doppler ultrasound synovitis in rheumatoid arthritis and psoriatic arthritis patients in remission or with low disease activity.Arthritis Res Ther2016https://conductscience.org/library/papers/27391315PubMed
323329363Calprotectin in rheumatoid arthritis : association with disease activity in a cross-sectional and a longitudinal cohort.Mol Diagn Ther2013https://conductscience.org/library/papers/23329363PubMed
419962617Laboratory tests to assess patients with rheumatoid arthritis: advantages and limitations.Rheum Dis Clin North Am2009https://conductscience.org/library/papers/19962617PubMed
522029973The soluble biomarker calprotectin (an S100 protein) is associated to ultrasonographic synovitis scores and is sensitive to change in patients with rheumatoid arthritis treated with adalimumab.Arthritis Res Ther2011https://conductscience.org/library/papers/22029973PubMed
626242859Calprotectin more accurately discriminates the disease status of rheumatoid arthritis patients receiving tocilizumab than acute phase reactants.Rheumatology (Oxford)2015https://conductscience.org/library/papers/26242859PubMed
723072741Treat-to-target: not as simple as it appears.Clin Exp Rheumatol2012https://conductscience.org/library/papers/23072741PubMed
825365085An evidence-based approach to laboratory tests in usual care of patients with rheumatoid arthritis.Clin Exp Rheumatol2014https://conductscience.org/library/papers/25365085PubMed
917234650Calprotectin (a major leucocyte protein) is strongly and independently correlated with joint inflammation and damage in rheumatoid arthritis.Ann Rheum Dis2007https://conductscience.org/library/papers/17234650PubMed
1019411389
Erythrocyte sedimentation rate, C-reactive protein, or rheumatoid factor are normal at presentation in 35%-45% of patients with rheumatoid arthritis seen between 1980 and 2004: analyses from Finland and the United States.
J Rheumatol2009https://conductscience.org/library/papers/19411389PubMed
1119095696Calprotectin (a major S100 leucocyte protein) predicts 10-year radiographic progression in patients with rheumatoid arthritis.Ann Rheum Dis2010https://conductscience.org/library/papers/19095696PubMed
12208725952010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.Arthritis Rheum2010https://conductscience.org/library/papers/20872595PubMed
1312784382Most patients receiving routine care for rheumatoid arthritis in 2001 did not meet inclusion criteria for most recent clinical trials or american college of rheumatology criteria for remission.J Rheumatol2003https://conductscience.org/library/papers/12784382PubMed
1420226018Work disability remains a major problem in rheumatoid arthritis in the 2000s: data from 32 countries in the QUEST-RA study.Arthritis Res Ther2010https://conductscience.org/library/papers/20226018PubMed
1515593206Proinflammatory S100 proteins in arthritis and autoimmune disease.Arthritis Rheum2004https://conductscience.org/library/papers/15593206PubMed
1616613612The S100A8/A9 heterodimer amplifies proinflammatory cytokine production by macrophages via activation of nuclear factor kappa B and p38 mitogen-activated protein kinase in rheumatoid arthritis.Arthritis Res Ther2006https://conductscience.org/library/papers/16613612PubMed
1711955534Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study.Lancet2002https://conductscience.org/library/papers/11955534PubMed
183313057Two calcium-binding proteins in infiltrate macrophages of rheumatoid arthritis.Nature1987https://conductscience.org/library/papers/3313057PubMed
1920215140Treating rheumatoid arthritis to target: recommendations of an international task force.Ann Rheum Dis2010https://conductscience.org/library/papers/20215140PubMed
2021791097Decreases in serum levels of S100A8/9 (calprotectin) correlate with improvements in total swollen joint count in patients with recent-onset rheumatoid arthritis.Arthritis Res Ther2011https://conductscience.org/library/papers/21791097PubMed

See all 30 referencesDownload CSV of references

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 23 citations.

PMIDTitleJournalYearIn PapersSource
42975821Pretreatment calprotectin level as a potential predictor of therapeutic response to tofacitinib in rheumatoid arthritis patients.Clin Rheumatol2026https://conductscience.org/library/papers/42975821PubMed
42516624Investigating the Correlation between Fecal Calprotectin and Gastrointestinal Involvement in Systemic Sclerosis Patients.Med J Islam Repub Iran2026https://conductscience.org/library/papers/42516624PubMed
41295301Predictive Biomarkers of Methotrexate Treatment Response in Patients with Rheumatoid Arthritis: A Systematic Review.Metabolites2025https://conductscience.org/library/papers/41295301PubMed
39740933Biomarkers reflecting disturbed gut barrier under treatment with TNF inhibitors in radiographic axial spondyloarthritis.RMD Open2024https://conductscience.org/library/papers/39740933PubMed
39174586A novel metric-based approach of scoring early host immune response from oro-nasopharyngeal swabs predicts COVID-19 outcome.Sci Rep2024https://conductscience.org/library/papers/39174586PubMed
38666958The Role of Alarmins in the Pathogenesis of Rheumatoid Arthritis, Osteoarthritis, and Psoriasis.Curr Issues Mol Biol2024https://conductscience.org/library/papers/38666958PubMed
36928900Calprotectin as new potential clinical marker for multiple myeloma.PLoS One2023https://conductscience.org/library/papers/36928900PubMed
35986420Calprotectin (S100A8/S100A9) detects inflammatory activity in rheumatoid arthritis patients receiving tocilizumab therapy.Arthritis Res Ther2022https://conductscience.org/library/papers/35986420PubMed
34718856Circulating levels of calprotectin, a signature of neutrophil activation in prediction of severe respiratory failure in COVID-19 patients: a multicenter, prospective study (CalCov study).Inflamm Res2022https://conductscience.org/library/papers/34718856PubMed
34386702Serum Calprotectin is Indicating Clinical and Ultrasonographic Disease Activity in Rheumatoid Arthritis, even with Normal C-Reactive Protein Levels.Mediterr J Rheumatol2021https://conductscience.org/library/papers/34386702PubMed
34288565Combinations of Anticyclic Citrullinated Protein Antibody, Rheumatoid Factor, and Serum Calprotectin Positivity Are Associated With the Diagnosis of Rheumatoid Arthritis Within 3 Years.ACR Open Rheumatol2021https://conductscience.org/library/papers/34288565PubMed
32955189Collagenous Gastritis in Children: Incidence, Disease Course, and Associations With Autoimmunity and Inflammatory Markers.Clin Transl Gastroenterol2020https://conductscience.org/library/papers/32955189PubMed
32818491Calprotectin in inflammatory bowel disease.Clin Chim Acta2020https://conductscience.org/library/papers/32818491PubMed
32010597The Role of Calprotectin in Rheumatoid Arthritis.J Transl Int Med2019https://conductscience.org/library/papers/32010597PubMed
31582902Calprotectin and Calgranulin C as Biomarkers of Pancreatic Tumors: Baseline Levels and Level Changes after Surgery.Mediators Inflamm2019https://conductscience.org/library/papers/31582902PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CRP1401PubTator's text mininghttps://conductscience.org/library/genes/1401

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/29656372

GET https://conductscience.org/api/papers/v1/29656372/references?page=2